These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23498893)

  • 1. Polyvalent complexes for vaccine development.
    Wang L; Huang P; Fang H; Xia M; Zhong W; McNeal MM; Jiang X; Tan M
    Biomaterials; 2013 Jun; 34(18):4480-92. PubMed ID: 23498893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Branched-linear and agglomerate protein polymers as vaccine platforms.
    Wang L; Xia M; Huang P; Fang H; Cao D; Meng XJ; McNeal M; Jiang X; Tan M
    Biomaterials; 2014 Sep; 35(29):8427-38. PubMed ID: 24985736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual vaccine candidate against norovirus and hepatitis E virus.
    Wang L; Cao D; Wei C; Meng XJ; Jiang X; Tan M
    Vaccine; 2014 Jan; 32(4):445-52. PubMed ID: 24291540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioengineered Norovirus S
    Xia M; Huang P; Sun C; Han L; Vago FS; Li K; Zhong W; Jiang W; Klassen JS; Jiang X; Tan M
    ACS Nano; 2018 Nov; 12(11):10665-10682. PubMed ID: 30234973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice.
    Tamminen K; Lappalainen S; Huhti L; Vesikari T; Blazevic V
    PLoS One; 2013; 8(7):e70409. PubMed ID: 23922988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus.
    Xia M; Wei C; Wang L; Cao D; Meng XJ; Jiang X; Tan M
    Sci Rep; 2016 May; 6():25735. PubMed ID: 27194006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus.
    Xia M; Wei C; Wang L; Cao D; Meng XJ; Jiang X; Tan M
    Vaccine; 2016 Feb; 34(7):905-13. PubMed ID: 26778421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.
    Malm M; Heinimäki S; Vesikari T; Blazevic V
    Clin Exp Immunol; 2017 Sep; 189(3):331-341. PubMed ID: 28407442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice.
    Xia M; Huang P; Jiang X; Tan M
    Vaccine; 2019 Jul; 37(30):4103-4110. PubMed ID: 31201052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A candidate dual vaccine against influenza and noroviruses.
    Xia M; Tan M; Wei C; Zhong W; Wang L; McNeal M; Jiang X
    Vaccine; 2011 Oct; 29(44):7670-7. PubMed ID: 21839795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual chicken IgY against rotavirus and norovirus.
    Dai YC; Zhang XF; Tan M; Huang P; Lei W; Fang H; Zhong W; Jiang X
    Antiviral Res; 2013 Mar; 97(3):293-300. PubMed ID: 23267830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and purification of norovirus virus like particles in Escherichia coli and their immunogenicity in mice.
    Huo Y; Wan X; Ling T; Wu J; Wang W; Shen S
    Mol Immunol; 2018 Jan; 93():278-284. PubMed ID: 28802994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
    Verma V; Tan W; Puth S; Cho KO; Lee SE; Rhee JH
    J Transl Med; 2016 May; 14(1):135. PubMed ID: 27184355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis.
    Blazevic V; Lappalainen S; Nurminen K; Huhti L; Vesikari T
    Vaccine; 2011 Oct; 29(45):8126-33. PubMed ID: 21854823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.
    Malm M; Tamminen K; Heinimäki S; Vesikari T; Blazevic V
    Vaccine; 2018 Jan; 36(4):484-490. PubMed ID: 29246474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.
    Tan M; Jiang X
    Nanomedicine (Lond); 2012 Jun; 7(6):889-97. PubMed ID: 22734641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological response to recombinant VP8* subunit protein of bovine roravirus in pregnant cattle.
    Lee J; Babiuk LA; Harland R; Gibbons E; Elazhary Y; Yoo D
    J Gen Virol; 1995 Oct; 76 ( Pt 10)():2477-83. PubMed ID: 7595351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Mol Immunol; 2016 Oct; 78():27-37. PubMed ID: 27573255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine.
    Blazevic V; Malm M; Arinobu D; Lappalainen S; Vesikari T
    Hum Vaccin Immunother; 2016 Mar; 12(3):740-8. PubMed ID: 26467630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.